Physician specializing in urologic oncology serves as an expert witness with more than 15 years of experience evaluating cancers of the genitourinary system. Clinical and academic work centers on the diagnosis and treatment of malignancies affecting the kidney, prostate, bladder, testicular, penile, and adrenal organs. Surgical management in this field includes robotic-assisted procedures, laparoscopic surgery, focal therapy, and open surgical techniques used to address urologic tumors. This expert has provided litigation consultation and courtroom testimony in matters involving urologic oncology and surgical management of genitourinary cancers. Educational training includes a Doctor of Medicine degree following undergraduate study in biological sciences, along with postgraduate residency training in urology and fellowship training in urologic oncology. The physician is board certified in Urology through the American Board of Urology and holds medical licensure to practice medicine.

A significant portion of this expert’s work focuses on kidney cancer, including research examining genetic alterations associated with tumor development and the biological mechanisms that contribute to disease progression and metastasis. Their broader oncology practice also encompasses prostate cancer and bladder cancer management, as well as evaluation of minimally invasive and robotic surgical approaches used in oncologic urology. These areas of practice inform analysis of medical decision-making, surgical technique selection, and disease progression in disputes involving the treatment of genitourinary malignancies. The expert currently holds an academic leadership role as a Professor of Urology and has previously served in program leadership and departmental roles including fellowship program direction in urologic oncology and chief-level hospital leadership in urology. Their professional activities have also included participation in national committees focused on urologic oncology and cancer-related clinical guidance.